000 | 01965 a2200553 4500 | ||
---|---|---|---|
005 | 20250516121638.0 | ||
264 | 0 | _c20130311 | |
008 | 201303s 0 0 eng d | ||
022 | _a1873-5835 | ||
024 | 7 |
_a10.1016/j.leukres.2012.10.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMpakou, Vassiliki E | |
245 | 0 | 0 |
_aDasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation. _h[electronic resource] |
260 |
_bLeukemia research _cFeb 2013 |
||
300 |
_a175-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aChromosomes, Human, Pair 21 |
650 | 0 | 4 | _aChromosomes, Human, Pair 8 |
650 | 0 | 4 | _aDasatinib |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aK562 Cells |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 | _aProtein Isoforms |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-kit _xgenetics |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
650 | 0 | 4 | _aTranslocation, Genetic |
650 | 0 | 4 |
_asrc-Family Kinases _xantagonists & inhibitors |
700 | 1 | _aKontsioti, Frieda | |
700 | 1 | _aPapageorgiou, Sotiris | |
700 | 1 | _aSpathis, Aris | |
700 | 1 | _aKottaridi, Christine | |
700 | 1 | _aGirkas, Kostas | |
700 | 1 | _aKarakitsos, Petros | |
700 | 1 | _aDimitriadis, George | |
700 | 1 | _aDervenoulas, Ioannis | |
700 | 1 | _aPappa, Vasiliki | |
773 | 0 |
_tLeukemia research _gvol. 37 _gno. 2 _gp. 175-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2012.10.011 _zAvailable from publisher's website |
999 |
_c22261230 _d22261230 |